Hazlett, Burt & Watson
BSX icon

Hazlett, Burt & Watson’s Boston Scientific BSX Stock Holding History

Hazlett, Burt & Watson’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$59K Sell
1,333
-78
-6% -$3.61K 0.02% 432
2026
Q2 		$61K Buy
1,411
+398
+39% +$21.6K 0.02% 434
2026
Q1 		$63K Hold
1,013
– – 0.02% 410
2025
Q4 		$98K Buy
1,013
+247
+32% +$24.2K 0.03% 346
2025
Q3 		$75K Buy
766
+220
+40% +$22.8K 0.03% 363
2025
Q2 		$59K Sell
546
-250
-31% -$25.3K 0.02% 350
2025
Q1 		$80K Sell
796
-30
-4% -$3.02K 0.04% 296
2024
Q4 		$74K Hold
826
– – 0.03% 310
2024
Q3 		$68K Hold
826
– – 0.03% 315
2024
Q2 		$64K Hold
826
– – 0.03% 302
2024
Q1 		$57K Buy
826
+160
+24% +$10.3K 0.03% 313
2023
Q4 		$38K Buy
666
+30
+5% +$1.6K 0.03% 343
2023
Q3 		$33K Hold
636
– – 0.02% 352
2023
Q2 		$33K Hold
636
– – 0.02% 354
2023
Q1 		$32K Hold
636
– – 0.03% 334
2022
Q4 		$30K Buy
636
+230
+57% +$10K 0.03% 332
2022
Q3 		$16K Hold
406
– – 0.02% 401
2022
Q2 		$15K Buy
406
+81
+25% +$3.3K 0.01% 409
2022
Q1 		$14K Buy
+325
New +$14.1K 0.01% 431

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hazlett, Burt & Watson's BSX Position: Q3 2026 in Review

Hazlett, Burt & Watson reduced its Boston Scientific (BSX) stake by 5.5% in Q3 2026, selling an estimated $3.61K and leaving 1,333 shares worth $59K. The position accounts for 0.02% of the portfolio, ranked #432.

Hazlett, Burt & Watson first reported a position in BSX in Q1 2022 and has held it in 19 quarters since. The position peaked at $98K in Q4 2025. 922 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Hazlett, Burt & Watson held 1,333 shares of Boston Scientific worth $59K as of Q3 2026.
  • Hazlett, Burt & Watson sold 78 Boston Scientific shares in Q3 2026, an estimated $3.61K.
  • Boston Scientific made up 0.02% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #432 holding.
  • Hazlett, Burt & Watson first reported a position in Boston Scientific in Q1 2022 and has held it in 19 quarters since.
  • Hazlett, Burt & Watson's Boston Scientific position peaked at $98K in Q4 2025.
  • 922 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.